Para-aminosalicylic acid (PAS) desensitization review in a case of multidrug-resistant pulmonary tuberculosis

Int J Tuberc Lung Dis. 2003 May;7(5):493-7.

Abstract

Setting: Tertiary care hospital in the Upper Midwest, United States.

Objective: Rapid desensitization to para-aminosalicylic acid (PAS) in a patient with previous hypersensitivity reaction and a review of published PAS desensitization protocols.

Design: Composition and implementation of a short-course PAS desensitization protocol for a 34-year-old woman with multidrug-resistant (MDR) pulmonary tuberculosis, incorporating published experiences of PAS desensitization over the past 50 years.

Results: We composed a protocol and successfully desensitized our patient to PAS (Paser granules). By starting with a low dose (50 mg), then doubling the PAS dose on each successive day, our patient was able to tolerate full dose in 1 week. No steroids were required and no adverse reactions were encountered. Previous published PAS desensitization protocols used starting doses of 10-500 mg, desensitization time ranges from 7 to 54 days and commonly used steroids or corticotropin.

Conclusion: Rapid desensitization to PAS can be successfully conducted within 1 week without the use of steroids or corticotropin. Given the limited number of drugs available for many patients with MDR-TB, desensitization to PAS is a valid alternative to drug discontinuation for patients with hypersensitivity reactions.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Aminosalicylic Acid / administration & dosage
  • Aminosalicylic Acid / immunology*
  • Antitubercular Agents / administration & dosage
  • Antitubercular Agents / immunology*
  • Desensitization, Immunologic*
  • Female
  • Humans
  • Tuberculosis, Multidrug-Resistant / drug therapy*
  • Tuberculosis, Multidrug-Resistant / immunology
  • Tuberculosis, Pulmonary / drug therapy*
  • Tuberculosis, Pulmonary / immunology

Substances

  • Antitubercular Agents
  • Aminosalicylic Acid